Stock Exchange Intimation
24 Jul 2026 – OneSource announces strong Q1FY27 results Revenue up 37% YoY and EBITDA up 39% YoY
24th July 2026
Stock Exchange Intimation
21 Jul 2026 – Intimation regarding Q1FY27 Earnings Call
21st July 2026
Stock Exchange Intimation
14 Jul 2026 – OneSource Specialty Pharma and Formycon AG announce Strategic Manufacturing Partnership for Biosimilars
14th July 2026
Stock Exchange Intimation
9 Jul 2026 – Intimation Under Regulation 30 – Clarification regarding delay in commercial supplies of Semaglutide.
9th July 2026
Stock Exchange Intimation
8 Jul 2026 – Intimation for: Allotment of shares pursuant to OneSource ESOP Scheme 2021
8th July 2026
Stock Exchange Intimation
2 Jul 2026 – Completion of US-FDA Inspection at Sterile Product Division facility at Bengaluru
2nd July 2026
Stock Exchange Intimation
24 Jun 2026 – Intimation of closure of Trading window for declaration of unaudited financial results for the quarter ended June 30, 2026
24th June 2026
Stock Exchange Intimation
19 May 2026 – Intimation of Transcript of Earnings call dated May 13, 2026
20th May 2026